Clear Cell Renal Cell Carcinoma — Trials

Clear Cell Renal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

247 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 114
Recruiting: 62
Ph III recruiting: 6
Growth YoY: −11.4%
Industry share: 30%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 44%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (39)

clinicaltrialsPublishedShowing 51–69 of 69 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01158521	Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney Cancer	completed	Phase 2	25	Case Comprehensive Cancer CenterOTHER	1	Sep 12, 2018	clinicaltrials
NCT01727089	Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer	completed	Phase 2	59	National Cancer Institute (NCI)NIH	3	Aug 28, 2018	clinicaltrials